No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr9:94527600-94538800 |
Weak transcription |
K562 |
blood
|
2 |
chr9:94529400-94539800 |
Enhancers |
Colon Smooth Muscle |
Colon
|
3 |
chr9:94532200-94539200 |
Enhancers |
Fetal Heart |
heart
|
4 |
chr9:94533000-94542800 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
5 |
chr9:94533000-94543600 |
Weak transcription |
Right Atrium |
heart
|
6 |
chr9:94533400-94549600 |
Weak transcription |
Colonic Mucosa |
Colon
|
7 |
chr9:94533600-94545400 |
Enhancers |
Stomach Smooth Muscle |
stomach
|
8 |
chr9:94534200-94538200 |
Genic enhancers |
Fetal Stomach |
stomach
|
9 |
chr9:94534400-94546800 |
Weak transcription |
Fetal Kidney |
kidney
|
10 |
chr9:94534600-94538800 |
Weak transcription |
Spleen |
Spleen
|
11 |
chr9:94534600-94539400 |
Weak transcription |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
12 |
chr9:94535000-94538600 |
Weak transcription |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
13 |
chr9:94535000-94539400 |
Weak transcription |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
14 |
chr9:94536000-94543200 |
Weak transcription |
iPS-15b Cell Line |
embryonic stem cell
|
15 |
chr9:94536000-94543600 |
Weak transcription |
HUES64 Cell Line |
embryonic stem cell
|
16 |
chr9:94536200-94544600 |
Weak transcription |
Placenta Amnion |
Placenta Amnion
|
17 |
chr9:94536400-94538400 |
Strong transcription |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
18 |
chr9:94536600-94538800 |
Weak transcription |
Placenta |
Placenta
|
19 |
chr9:94537000-94543400 |
Weak transcription |
Duodenum Smooth Muscle |
Duodenum
|
20 |
chr9:94537200-94539800 |
Enhancers |
Primary neutrophils fromperipheralblood |
blood
|
21 |
chr9:94537400-94538200 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
22 |
chr9:94537600-94538200 |
Enhancers |
Fetal Intestine Large |
intestine
|
23 |
chr9:94537600-94538200 |
Bivalent Enhancer |
Fetal Muscle Trunk |
muscle
|
24 |
chr9:94537600-94538200 |
Enhancers |
Ovary |
ovary
|
25 |
chr9:94537600-94538600 |
Enhancers |
ES-UCSF4 Cell Line |
embryonic stem cell
|
26 |
chr9:94537600-94538800 |
Enhancers |
HUES6 Cell Line |
embryonic stem cell
|
27 |
chr9:94537600-94538800 |
Enhancers |
Fetal Lung |
lung
|
28 |
chr9:94537600-94539600 |
Enhancers |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
29 |
chr9:94537800-94538200 |
Weak transcription |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
30 |
chr9:94537800-94538200 |
Bivalent Enhancer |
Primary B cells from peripheral blood |
blood
|
31 |
chr9:94537800-94538200 |
Bivalent Enhancer |
Primary T cells fromperipheralblood |
blood
|
32 |
chr9:94537800-94538800 |
Weak transcription |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
33 |
chr9:94537800-94541000 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
34 |
chr9:94537800-94543400 |
Weak transcription |
H9 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
35 |
chr9:94537800-94545000 |
Weak transcription |
Fetal Intestine Small |
intestine
|
36 |
chr9:94537800-94546000 |
Weak transcription |
Gastric |
stomach
|
37 |
chr9:94538000-94538200 |
Bivalent Enhancer |
Fetal Muscle Leg |
muscle
|
38 |
chr9:94538000-94538600 |
Enhancers |
iPS-18 Cell Line |
embryonic stem cell
|
39 |
chr9:94538000-94538800 |
Weak transcription |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
40 |
chr9:94538000-94538800 |
Enhancers |
HUES48 Cell Line |
embryonic stem cell
|
41 |
chr9:94538000-94539400 |
Enhancers |
Rectal Smooth Muscle |
rectum
|
42 |
chr9:94538000-94540400 |
Enhancers |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
43 |
chr9:94538000-94540400 |
Enhancers |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
44 |
chr9:94538000-94540600 |
Enhancers |
NHLF |
lung
|
45 |
chr9:94538000-94541000 |
Enhancers |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
46 |
chr9:94538000-94548800 |
Weak transcription |
Esophagus |
oesophagus
|